Progeria is a rare genetic condition that produces rapid aging in children.
Progeria is a rare condition. It is remarkable because its symptoms strongly resemble normal human aging, but it occurs in young children. In most cases, it is not passed down through families. It is rarely seen in more than one child in a family.
- Growth failure during the first year of life
- Narrow, shrunken or wrinkled face
- Loss of eyebrows and eyelashes
- Short stature
- Large head for size of face (macrocephaly)
- Open soft spot (fontanelle)
- Small jaw (micrognathia)
- Dry, scaly, thin skin
- Limited range of motion
- Teeth - delayed or absent formation
Exams and Tests
The health care provider will perform a physical exam and order laboratory tests. This may show:
- Insulin resistance
- Skin changes similar to that seen in scleroderma (the connective tissue becomes tough and hardened)
- Generally normal cholesterol and triglyceride levels
Cardiac stress testing may reveal signs of early atherosclerosis of blood vessels.
Genetic testing can detect changes in the gene (LMNA) that causes progeria.
There is no specific treatment for progeria. Aspirin and statin medicines may be used to protect against a heart attack or stroke.
Progeria Research Foundation, Inc. -- www.progeriaresearch.org
Progeria causes early death. People with the condition most often only live to their teenage years (average lifespan of 14 years). However, some can live into their early 20s. The cause of death is very often related to the heart or a stroke.
Complications may include:
- Heart attack (myocardial infarction)
When to Contact a Medical Professional
Call your provider if your child does not appear to be growing or developing normally.
Hutchinson-Gilford progeria syndrome; HGPS
Gordon LB. Hutchinson-Gilford progeria syndrome. In: Kliegman RM, Stanton BF, St. Geme JW, Schor NF, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia, PA: Elsevier; 2016:chap 90.
Gordon LB, Brown WT, Collins FS. Hutchinson-Gilford progeria syndrome. Gene Reviews. 2015:1. PMID: 20301300 www.ncbi.nlm.nih.gov/pubmed/20301300.
Review Date 8/6/2017
Updated by: Anna C. Edens Hurst, MD, MS, Assistant Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.